Figure 4
Western blot images (A) and summary of effects of ketamine on the expression level of PSD-95, pY53 and NR2B (B) in somatosensory cortex at 24 and 72 hours after the start of subchronic treatment. *Indicates p < 0.05.
Figure 4 | Scientific Reports
